tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Peters, 33 are a BUY (97.06%), 1 are a HOLD (2.94%).
Analyst Andrew Peters works with a stock forecast success ratio of 86.75% fulfilled within 659.56 days on average. Previously, Andrew Peters worked at DEUTSCHE BANK, UBS.
Andrew Peters’s has documented 79 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ESPR, Esperion Therapeutics at 03-May-2018.
Analyst best performing recommendations are on EXEL (EXELIXIS).
The best stock recommendation documented was for HALO (HALOZYME THERAPEUTICS) at 11/3/2016. The price target of $12 was fulfilled within 7 days with a profit of $3.54 (41.84%) receiving and performance score of 59.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
91
$-0.2 (-0.22%)
91
1 months 28 days ago
2/6 (33.33%)
$4.72 (5.47%)
33
Hold
100
$8.8 (9.65%)
100
2 months 3 days ago
1/6 (16.67%)
$8.76 (9.60%)
41
Buy
107
$15.8 (17.32%)
115
2 months 3 days ago
15/32 (46.88%)
$15.76 (17.27%)
454
Buy
104
$12.8 (14.04%)
127
2 months 27 days ago
1/4 (25%)
$14.38 (16.05%)
415
Buy
170
$78.8 (86.40%)
185
5 months 24 days ago
6/11 (54.55%)
$90.33 (113.38%)
321
What Year was the first public recommendation made by Andrew Peters?
